NovaBay Pharmaceuticals, Inc.
Ticker: 1389545
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
2.14
-3.2%+311.5%
Expenditure
-53.82
-196.0%-3123.6%
Net Profit
50.36
+222.6%+4003.9%
OPM %
100.00%
+200.00pp+200.00pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingNBY
202610Nov
Board Meeting
The Company's stockholders elected three Class I directors a…
SEC Filing ↗ Board MeetingNBY
20262Sep
Board Meeting
David Garcia Rios appointed as a Class II director to the Bo…
SEC Filing ↗ Board MeetingNBY
202615Jul
Board Meeting
Chief Operating Officer Appointment — Henry Blynn appointed …
SEC Filing ↗